Recommend Cell Cycle to your librarian for 2008. Download form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Perspectives

Prostaglandin E2: Making More of Your Marrow

Allegra M. Lord, Trista E. North and Leonard I. Zon

volume 6 | issue 24

15 December 2007
Pages: 3054 - 3057

Purchase article for $19

Subscribe to this journal for $129/year

We have recently demonstrated through a chemical screen in the zebrafish embryo that prostaglandin E2 (PGE2) is an evolutionarily conserved regulator of hematopoietic stem cell (HSC) number. These results have further been confirmed by in vitro and in vivo studies in the murine model. Bioactive PGE2 derivatives have potential clinical application to accelerate recovery of the hematopoietic system following chemotherapy or irradiation. Ex vivo expansion of HSCs prior to stem cell transplantation may improve reconstitution of hematopoiesis and immune function. This article aims to summarize current knowledge of PGE2-mediated regulation of blood cell homeostasis as well as to discuss the proposed use of PGE2 to expand hematopoietic stem cells for transplantation in the clinical setting.

Authors

Allegra M. Lord

Harvard Medical School; Boston, MA

Trista E. North

Harvard Medical School; Boston, MA

Leonard I. Zon

Harvard Medical School; Boston, MA


Purchase article for $19

Subscribe to this journal for $129/year